Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma
Journal Article
·
· Cancer Treat. Rep.; (United States)
OSTI ID:5723414
The optimal use of ''prophylactic'' cranial irradiation (PCI) in patients with small cell lung cancer remains undetermined. This study reviews the impact of PCI, given at complete remission (CR), on neurologic relapse in 172 consecutive patients with small cell lung cancer treated in three sequential chemotherapy protocols at the University of Maryland Cancer Center. In the first study of 38 patients, none received PCI. In the second study of 109 patients, the first 28 achieving CR were randomized to 3000 rad of PCI in ten fractions (PCI+) or to observation (PCI-). Thereafter, based on interim analysis, all patients achieving CR received PCI. In the third study, to date, 25 patients achieving CR have received PCI. Overall, 169 patients were evaluable for neurologic relapse, and 30 of 90 patients achieving CR received PCI. Among all patients with CR, with adjustment for disease extent, there was a significant delay to any neurologic relapse (P . 0.01) and cerebral metastases (P . 0.02) for PCI+ compared to PCI- patients. Among PCI- patients with CR, cerebral metastases alone occurred in 28% as the sole site and in 33% as the initial site, whereas cerebral relapse occurred prior to systemic relapse in only one PCI+ patient with CR. Patient survival however, was not significantly altered by PCI. PCI at CR confers effective and worthwhile local control in the CNS, especially during periods of systemic response, and a small percentage of patients may benefit. Systemic drug resistance still determines overall survival.
- Research Organization:
- University of Maryland Cancer Center, Baltimore, MD
- OSTI ID:
- 5723414
- Journal Information:
- Cancer Treat. Rep.; (United States), Journal Name: Cancer Treat. Rep.; (United States) Vol. 67:7-8; ISSN CTRRD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution
Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial)
Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung
Journal Article
·
Sat Feb 28 23:00:00 EST 2009
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21172625
Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial)
Journal Article
·
Sun Aug 15 00:00:00 EDT 2021
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:23198484
Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung
Journal Article
·
Sat Sep 30 00:00:00 EDT 1995
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:437126
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ADULTS
AGE GROUPS
BODY
BRAIN
CARCINOMAS
CENTRAL NERVOUS SYSTEM
CHEMOTHERAPY
DISEASES
EVALUATION
FEMALES
FRACTIONATED IRRADIATION
IRRADIATION
LUNGS
MALES
MEDICINE
METASTASES
NEOPLASMS
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NUCLEAR MEDICINE
ORGANS
PATIENTS
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
THERAPY
62 RADIOLOGY AND NUCLEAR MEDICINE
ADULTS
AGE GROUPS
BODY
BRAIN
CARCINOMAS
CENTRAL NERVOUS SYSTEM
CHEMOTHERAPY
DISEASES
EVALUATION
FEMALES
FRACTIONATED IRRADIATION
IRRADIATION
LUNGS
MALES
MEDICINE
METASTASES
NEOPLASMS
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NUCLEAR MEDICINE
ORGANS
PATIENTS
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
THERAPY